Liver cancer is one of the top six leading causes of cancer-related death. Radiofrequency ablation (RFA) is an important means of treating liver cancer. Residual cancer after RFA is the most frequent cause of recurrence in cases of liver cancer. The main difference between residual cancer cells and ordinary liver cancer cells is that residual cancer cells experience heat shock. The secretable form of trimeric human tumor necrosis factor-related apoptosis-inducing ligand (stTRAIL) induces apoptosis in a variety of human cancers but not in normal tissues. It has shown potent cancer-selective killing activity and has drawn considerable attention as a possible cancer therapy. In the present work, the therapeutic potential of this stTRAIL-based gene therapy was evaluated in hepatocellular carcinoma subjected to RFA. Rat bone marrow mesenchymal stem cells (BM-MSCs) were isolated and transduced with a lentiviral vector encoding stTRAIL (stTRAIL-MSCs, T-MSCs). Cells treated with heat treatment at 43 1C for 45 min served as simulated residual cancer cells. After treatment with T-MSCs, apoptosis in heat-shock-treated liver cancer cells increased significantly, and caspase-3 was upregulated. When T-MSCs were subcutaneously injected into nude mice, they localized to the tumors and inhibited tumor growth, significantly increasing survival. Collectively, the results of the present study indicate that BM-MSC can provide a steady source of stTRAIL and may be suitable for use in the prevention of the recurrence of hepatocellular carcinoma after RFA with secretable trimeric TRAIL.
INTRODUCTION
Liver cancer is one of the top six leading tumors that cause cancerrelated deaths, as reported in worldwide cancer statistics.
1,2 Liver resection, orthotopic liver transplantation, and thermal ablation are currently the three treatments available to liver cancer patients. Liver resection is suitable for only 15-30% of patients. 3 The selection criteria for orthotopic liver transplantation remain debatable, and the supply of livers for transplants is limited. Thermal ablation, such as radiofrequency ablation (RFA), is widely used to treat nonresectable and small liver tumors (p3 cm). It may cause tumor clearance and increase quality of life. The efficacy of RFA for tumors smaller than 3 cm in diameter is the same as that of liver resection. 4 However, a recent study has shown that local recurrences of RFA occur B9-18% of the time. 5 Complete tumor destruction is made difficult by the technical limitations of RFA, especially in the case of larger tumors. The undefined volume of the lesions results in incomplete damage, which can then cause residual lesions. This can in turn cause tumor recurrence, which is the main drawback of RFA for liver cancer. Tumor recurrence occurs mainly at the transition zone of RFA, where the temperature is too low to cause cell death (60-42 1C). There have not been many studies evaluating changes in the biology of tumor cells exposed to RFA or evaluating improvements in the efficacy of RFA through enhancement of direct damage.
Increasing the amount of indirect damage caused by thermal ablation may be an important means of reducing the rate of residual cancer.
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is a type II transmembrane cytokine molecule of the tumor necrosis factor family. 6 It has been shown to induce cell apoptosis in many types of tumors but not in normal cells. The secreted form of trimeric TRAIL (stTRAIL) is a trimer, as described by Kim et al. 7 stTRAIL was first discovered only recently, and it has many possible applications, including the treatment of malignant glioma. 8, 9 It can promote tumor cell apoptosis and has an even stronger apoptotic function than full-length TRAIL. 10 The ability of TRAIL to promote apoptosis in tumor cells has been shown to be temperature sensitive. 11 Bone marrow-derived mesenchymal stem cells (BM-MSCs) are used in many laboratories, because there is an abundant supply, they are easy to separate and culture, they are non-immunogenic and immunosuppressive, they have an anti-inflammatory function, they have a high migratory capacity toward inflamed and remodeling tissues, and they can carry genes. 12 In the present work, cultured cells were subjected in vitro to hyperthermia (43 1C) to mimic the transition zone produced by RFA. The effect of T-MSCs (stTRAIL-MSCs, LVs-stTRAIL-transduced MSC cells) on apoptosis among heat-shock-treated liver cancer 1 cells and tumors was evaluated in this way. The purpose of the present work was to explore the feasibility of this new biological method of improving the efficacy of RFA for the treatment of liver cancer.
RESULTS
Genetically modified BM-MSC cells express high levels of stTRAIL BM-MSCs were subjected to flow cytometric analysis using antibodies against CD29, CD90, and CD45. Data showed that BM-MSCs to be positive for CD29 and CD90 but not CD45, a typical lymphocytic marker (Figure 1a) . This was consistent with the results of previous reports. 13 Adipogenic and osteogenic differentiation assays confirmed that the BM-MSCs that had been isolated and cultured were capable of multilineage differentiation (Figure 1b) . BM-MSCs that had been passaged three times were transduced with LVs-stTRAIL and control lentiviruses (LVs-vector). Green fluorescent protein expression was detected using Zeiss LSM510 and a META confocal microscope (Oberkochen, Germany) (Figure 1c) , and the level of stTRAIL was assessed at different times ( Figure 1d ). The level of stTRAIL decreased over time, but stTRAIL continued to be produced for up to 21 days. The level of stTRAIL messenger RNA (mRNA) in the T-MSCs (stTRAIL-MSCs, LVs-stTRAIL-transduced MSC cells) was significantly higher than in V-MSCs (Vector-MSCs, LVs-vector-transduced MSC cells) (Figure 1e ). These data indicate that BM-MSCs are not affected by LV transduction or stTRAIL expression.
T-MSCs can undergo directional migration in vitro
MSCs have been shown to migrate directly to tumors. Because of this tumor-targeting property, MSC migration was here assayed in vitro using transwell plates. T-MSCs and V-MSCs were co-cultured with heat-shocked and unshocked N1-S1, HepG2, MHCC97-H, and L02 cells using the transwell system. Only a few cells migrated toward conditioned medium from L02 or HS-L02 cells, but a significant number of T-MSCs migrated toward conditioned medium from heat-shocked N1-S1, HepG2, and MHCC97-H cells (Po0.001). This was not the case with conditioned medium from untreated N1-S1, HepG2 or MHCC97-H cells (Figures 2a and b) . Significantly greater T-MSC migration was T-MSCs may improve the efficacy of RFA Q Deng et al stimulated by conditioned medium from HS-N1-S1, HS-HepG2, and HS-MHCC97-H than medium from N1-S1, HepG2 or MHCC97-H cells (Po0.001). This suggests that T-MSCs can migrate to heat-treated tumor cells. T-MSCs showed a more pronounced ability to migrate than V-MSCs. This is consistent with the findings of previous studies. 14 As reported, the CXCR4/SDF-1a pathway may have a role in the migration of MSCs. For this reason, the level of expression of SDF-1a was determined in the culture supernatant of HepG2 and MHCC97-H cells. Results showed that heat-shocked liver cancer cells express more SDF-1a than untreated cells (Figure 2c ).
T-MSCs induce apoptosis in heat-shocked tumor cells in vitro Cells were collected and then assayed for apoptosis using transmission electron microscopy. The results showed the formation of apoptotic bodies among T-MSCs and in the heatshocked group (Figure 3a) . Results confirmed the occurrence of apoptosis among N1-S1, HepG2, and MHCC97-H cells after treatment. Then a cell death assay was performed using annexin V-PI staining and flow cytometry. T-MSCs were found to promote a higher degree of apoptosis among heat-shocked liver cancer cells than among other types of cells (Figures 3b, c and Figure 4A ). The level of expression of the death receptors DR4 and DR5 was measured in N1-S1, HepG2, and MHCC97-H cells and the level of expression of death decoy receptors DcR1 and DcR2 was measured in HepG2 and MHCC97-H cells. DR4 and DR5 mRNA were found to be expressed but DcR1 and DcR2 mRNA were barely detectable ( Figure 4B ).
Caspase pathway may participate in the apoptotic pathway TRAIL activates caspase-3 as an initial apoptotic signaling event. In the current T-MSC experiments, the mRNA and protein expression levels of caspase-3 were found to have increased (Figures 4c and d) . These results indicate that the caspase pathway participates in stTRAIL-mediated apoptosis among heat-treated liver cancer cells.
T-MSCs exhibited directional migration to the tumor site and exerted antitumor activity in vivo HS-N1-S1 and N1-S1 were subcutaneously injected into nude mice at the right groin and the T-MSCs, V-MSCs, L02, and phosphatebuffered saline (PBS) were injected into the left groin. We assessed the tumor suppressor activity by measuring tumor sizes from day 0 to the natural death of the nude mice ( Figure 5A ). Injection with T-MSCs significantly inhibited tumor growth in nude mice. However, large tumors were detected in the V-MSC, L02, and PBS groups (Figures 5A and C). Nude mice in the T-MSC group survived longer than mice in the other groups ( Figure 5B ). To confirm that the reductions in tumor growth were due to the presence of injected T-MSCs, cells in tumor sections were counted ( Figure 5D) . A large number of T-MSCs were observed gathered around the tumor tissues at the time of the natural death of the nude mice (Figure 5Da ), and HS-N1-S1 hepatoma cell growth was suppressed. T-MSCs were also observed gathered around N1-S1 tumor tissues ( Figures 5D and B ) (Po0.05). However, tumor volume was greater than in the T-MSCs/HS-N1-S1 group. This indicated that T-MSCs promote more apoptosis in heatshocked liver cancer cells than in untreated liver cancer cells.
The frequency of apoptosis in tumor tissues and cells was further examined by terminal deoxynucleotidyl transferase dUTP nick end labeling staining, which showed more apoptotic cells in the T-MSC-treated tumors grown from heat-shocked N1-S1 cells (T-MSCs/HS-N-S1) ( Figure 5E a and f) than in tumors in other groups (Figures 5E, b-e, and g-j) (Po0.05). Apoptosis was also observed in T-MSC-treated tumors grown from N1-S1 cells (Figures 5E, b, and g), but there were fewer of them than in the T-MSCs/HS-N1-S1 group (Po0.05).
T-MSCs cells have no in vivo toxicity
It has been reported that TRAIL and BM-MSCs have some undesirable effects, including liver toxicity. 15, 16 It has also been reported that TRAIL-MSCs have no liver toxicity. 17 A hepatotoxicity assay was performed, as reported previously. 17 Rats that had been subcutaneously (s.c.) injected on the flank and intravenously (i.v.) injected at the caudal vein with 1 Â 10 6 T-MSCs or 1 Â 10 6 V-MSCs were assayed for serum levels of alanine aminotransferase and aspartate aminotransferase. Both aspartate aminotransferase and alanine aminotransferase levels were within the normal range in all T-MSC and V-MSC groups (alanine aminotransferase: P ¼ 0.716, i.v. group, P ¼ 0.854, s.c. group; aspartate aminotransferase: (Figure 6a) . 18, 19 These data were confirmed by hematoxylin and eosin staining of the liver tissue (Figure 6b ), which showed no signs of inflammatory cell infiltration. The behavior, feeding habits, and weight of treated rats were observed. As shown in Figure 6c , neither i.v. (left) and s.c.
(right) injections of T-MSCs or V-MSCs were found to affect weight gain (P ¼ 0.86, i.v. group and P ¼ 0.18, s.c. group). Similarly, food intake, behavior, and the results of the necropsy, which was performed at 60 days, were normal (data not shown). In summary, T-MSCs were not found to cause liver toxicity or affect the behavior, diet or body weight of the laboratory rats.
DISCUSSION
Tumor recurrence in the transition zone is a major problem with RFA of liver cancer. Because the local high temperature of the transition zone in RFA increases the sensitivity of tumor cells to drugs, radiotherapy, and the immune response, studies have focused on extending the indirect damage caused by RFA. 20 Such measures have involved combining RFA with Ad-stTRAIL, 9 lysothermosensitive liposomal doxorubicin, 5-FU, 21 IL-7, IL-15, 22 endostatin 23 , and radiotherapy. 24 Ad-stTRAIL 25 and lysothermosensitive liposomal doxorubicin 26 have entered phase I clinical trials. In the present work, the conditions of the RFA transition zone were simulated with heat treatment (43 1C for 45 min) in the cultured cells. T-MSCs were found to significantly promote apoptosis among heat-shocked liver cancer cells through their secretion of stTRAIL protein and activation of the caspase pathway. The expression of caspase-3 also increased. Promoting apoptosis among tumor cells is an important means of treating tumors. 27 Apoptosis is also relevant to the indirect damage caused by RFA treatment. It has been proven to significantly increase the rate of apoptosis among tumor cells in the transition zone after RFA. 28 The hypoxic environment that RFA has been reported to create in the transition zone can accelerate tumor growth. 29 Tumor cells that survive the slightly elevated temperature in the microenvironment are the main cells responsible for tumor recurrence.
stTRAIL gene therapy is one of the most effective methods of cancer gene therapy, and stTRAIL is an important target of pharma projects designed to produce anticancer drugs. 25 Far smaller tumors were detected in nude mice in the T-MSC/HS-N1-S1 group than in mice in the T-MSC/N1-S1, V-MSC/HS-N1-S1, L02/HS-N1-S1, and PBS/HS-N1-S1 groups. (B) Survival curve of subcutaneous liver cancer-bearing nude mice. On day 2 after HS-N1-S1 or N1-S1 (2 Â 10 5 cells) s.c. inoculation, tumors were injected with a single dose (2 Â 10 5 cells) of T-MSCs (n ¼ 6) or V-MSCs (n ¼ 6), L02 (n ¼ 6), and PBS (n ¼ 6). Analysis of survival was conducted using a log-rank test based on the Kaplan-Meier method. (C) Representative tumor specimens taken from each nude mouse s.c. injected with HS-N1-S1 and T-MSC, V-MSC, L02, and PBS and injected with N1-S1 and T-MSC were collected. (D) Representative fluorescence photomicrographs of DiI-stained (red) BM-MSCs were obtained from mice subcutaneously injected with (a) HS-N1-S1 and T-MSC, (b) N1-S1 and T-MSC, (c) HS-N1-S1 and V-MSC, (d) HS-N1-S1 and L02, and (e) HS-N1-S1 and PBS. The presence of red cells within the tumor burden confirmed that transduction had taken place. BM-MSC localization ( Â 100). (E) (a-e) Representative fluorescence photomicrographs and (f-j) bright field microscopy images of apoptosis among tumor tissues cells obtained from mice s.c. injected with (a, f) HS-N1-S1 and T-MSC, (b, g) N1-S1 and T-MSC, (c, h) HS-N1-S1 and V-MSC, (d, i) HS-N1-S1 and L02, (e, j) HS-N1-S1 and PBS using terminal deoxynucleotidyl transferase dUTP nick end labeling staining. Arrows indicate apoptotic cells.
express death receptors that is beneficial to stTRAIL gene therapy. Results confirmed that stTRAIL can exert proapoptotic effects on tumor cells that have been heat treated. The RFA transition zone is hyperthermic and an important region in residual cancer occurrence. In liver cancer, the major drawback of RFA treatment is recurrence, and the main cause of recurrence is residual foci. For this reason, promoting cell death in the residual foci is an important way of improving the efficacy of RFA. Studies have demonstrated that human umbilical cord blood-derived mesenchymal stem cells are stTRAIL carriers, delivering stTRAIL to the tumor site, where it can promote apoptosis. 9 stTRAIL is sensitive to temperature. 32 The results of the present study showed that BM-MSCs can carry stTRAIL, which can promote apoptosis among heat-shocked liver cancer cells. This indicates that BM-MSCs carry stTRAIL to the tumor site, thereby increasing the expression of stTRAIL in the transition zone. This increases the T-MSCs may improve the efficacy of RFA Q Deng et al rate of apoptosis among tumor cells in this area, which is an effective way of reducing the occurrence of residual tumors after RFA. The liver cancer cells used in these experiments were heated to the same temperature observed in the transition zone of liver cancer patients treated with RFA. T-MSCs were found to promote apoptosis among heat-shocked liver cancer cells. Animal studies confirmed that T-MSCs can migrate to the tumor site and inhibit tumor growth. T-MSCs may migrate to the tumor site through the CXCR4/SDF-1a signaling pathway. 32 In vitro experiments showed that the migration of T-MSCs was more pronounced in the heatshocked group than in untreated groups. It remains to be determined whether the expression of CXCR4/SDF-1a in heatshocked liver cancer cells changed accordingly.
The experiments performed in this study simulated RFA in cell culture vessels. Due to the various limitations of this system, RFA could not be performed on xenograft tumors in nude mice. Maarten W. Nijkamp established a rat colorectal cancer liver metastasis model and conducted RFA procedures. 29 However, it is difficult to establish experimental animal models of hepatocellular carcinoma in situ, so most of the experimental studies have used ectopic subcutaneous tumor model to conduct relevant research, instead relying on nude mice and immunodeficient rats. This experiment involves RFA procedures, because of the small livers of nude mice and SD rats, the diameter of the RF needle, and the fact that most animal RFA instruments do not meet operational requirements. An experimental subcutaneous tumor model was used here. Cells were heat-shocked for 45 min at 43 1C to simulate the RF ablation process before hepatoma cell transplant, and heatshocked hepatoma cells were transplanted into nude mice with the culture supernatant. This model has some deficiencies, but it also minimizes the transition zone microenvironment of RFA. The next step is to make use of an animal model of hepatocellular carcinoma, and subject these animals to RFA.
The properties of stTRAIL and BM-MSCs were here evaluated for the purpose of improving the efficacy of RFA. First, T-MSCs were found to migrate to the tumor site. In vivo, this would be the transition zone, which is one area where residual cancer tends to occur. stTRAIL was found to selectively promote apoptosis among tumor cells, and hyperthermia did not affect the antitumor effects of stTRAIL or the secretion of stTRAIL by BM-MSCs. T-MSCs were found to target the desired site effectively, to treat the tumors effectively, and to be reasonably safe. It was confirmed that T-MSCs in the RFA transition zone can promote apoptosis among residual cancer cells, as indicated by in vitro and in vivo experiments. T-MSCs combined with RFA were found to increase the severity of indirect damage caused by RFA and to expand the range of RFA damage and so reduce tumor recurrence and metastasis. Collectively, these results provide preclinical theoretical support for a model of stTRAIL-based RFA cancer therapy that relies on the use of BM-MSC as cellular vectors. In this way, this paper provides a new biological strategy that may be suitable for improving the efficacy of RFA in liver cancer patients.
MATERIALS AND METHODS

Animal care and procedures
All experiments were carried out in accordance with the guidelines of the Animal Care Committee of the Third Military Medical University of China. SD rats (6-8 weeks) and female nude mice were purchased from the animal center of Daping Hospital, which is affiliated with the Third Military Medical University (Chongqing, China). Nude mice were housed in a specific-pathogen-free facility with laminar air flow units that were light and temperature controlled. Sterile laboratory chow and water were available ad libitum.
Cell culture
Rat liver cancer N1-S1 cells and human liver cancer HepG2 cell lines were obtained from the American Type Culture Collection (Rockville, MD, USA).
A human liver cancer MHCC97-H cell line and normal human hepatocytes L02 were obtained from the Shanghai Institute of Cell Biology, Chinese Academy of Sciences (Shanghai, China). Cells were maintained in high-glucose DMEM (Dulbecco's modified Eagle's medium) (GIBCO, Invitrogen, Grand Island, NY, USA) supplemented with 10% fetal bovine serum and 1% penicillin-streptomycin at 37 1C in a 5% CO 2 atmosphere. SD rat bone marrow-derived mesenchymal stem cells (BM-MSCs) were isolated and grown as in previous studies. 33, 34 Construction of LVs-stTRAIL and LVs-vector A recombinant replication-deficient lentiviral expression plasmid with selection marker green fluorescent protein (pCDH-EF1-MCS-T2A-copGFP) was obtained from System Biosciences. (CD521A-1) and engineered to contain all the necessary DNA sequences for expressing secretable trimeric TRAIL (stTRAIL), as described in a previous study. 7 Clones with the right sequence were chosen for further processing using lentiviral packaging plasmids (pRsv-REV, pMDlg-pRRE, and pMD2G). Lentiviruses carrying the stTRAIL gene are here called LVs-stTRAIL, and the empty vector lentivirus. LVs-vector served as a control.
Establishment of T-MSC and V-MSC cells
MSCs that had been passaged for three generations were used for experiments. First, 3 Â 10 4 cells were plated in each well of 12-well plates. After 24 h, MSCs were infected with experimental lentiviruses (LVs-stTRAIL) and control lentiviruses (LVs-vector) at a multiplicity of infection (MOI) of 30. The LVs-stTRAIL and LVs-vector were diluted in ice-cold serum-free medium, and then cells were incubated with the diluted virus for 8 h, washed once with PBS, and returned to the original growth medium. After viral transduction, the culture supernatants were collected at different points in time and then either used for apoptosis or stored at À 80 1C. Heat treatment and conditioned culture of cells The N1-S1, HepG2, and MHCC97-H cells were heat-shocked at 43 1C for 45 min in a CO 2 incubator (SHELL/JB TC 2323, U.S.) and returned to the incubation chamber for 24 h at 37 1C. The conditioned media from T-MSC and V-MSC cell cultures were collected and centrifuged. Supernatants were passed through 0.20 mm pore-sized filters (Sartorius, Goettingen, Germany) and saved for later use with the heat-shocked and untreated liver cancer cells, which were subsequently cultured for the indicated lengths of time.
ELISA for secreted stTRAIL and SDF-1a
The concentration of human stTRAIL protein was measured using a Quantikine Human TRAIL/TNFSF10 Immunoassay Kit (DTRL00, R&D Systems, Minneapolis, MN, USA) according to manufacturer's instructions. The concentration of human SDF-1a protein was measured using a Human CXCL12/SDF-1 Alpha Quantikine ELISA Kit (DSA00, R&D Systems) according to the manufacturer's instructions.
In vitro cell migration assay
The migratory ability of T-MSCs was determined using Transwell plates (Corning Costar). These plates were 6.5 mm in diameter with 8 mm pore filters. Then 600 ml cell suspensions of treated and untreated N1-S1, HepG2, MHCC97-H, and L02 were placed in the lower well of a Transwell plate at a concentration of 2 Â 10 5 ml À 1 in complete medium and then incubated for 24 h. Then 400 ml cell suspensions of T-MSCs and V-MSCs were diluted in conditioned medium at concentrations of 2 Â 10 4 . These were added to the upper well. After incubation for 48 h at 37 1C, cells that had not migrated from the upper side of the filters were scraped off with a cotton swab. Filters were stained with crystal violet (C0120, Beyotime Biotechnology, Haimen, China) and cells were counted under a light microscope (Olympus Â B 40) at Â 10 magnification (five fields per well, triplicate wells). Experiments were performed in triplicate. Transmission electron microscopy N1-S1, HepG2, and MHCC97-H cells were seeded into 24-well plates and incubated for 24 h. The N1-S1, HepG2, and MHCC97-H cells were heatshocked and incubated for another 24 h at 37 1C. Then the conditioned media from T-MSCs and V-MSCs was added and the mixture was cultured for 48 h. The liver cancer cells were fixed with 2.5% glutaraldehyde, and then rinsed three times (30 min per time) with 0.1 M PBS. Cells were fixed with 1% osmium tetroxide for 2 h and then gradient-dehydrated in acetone, saturated, and embedded in epoxy 618. The samples were positioned in semi-thin slices and then ultra-thin slices were made and stained with uranium and lead. Finally, apoptosis among heat-shocked N1-S1, HepG2, and MHCC97-H cells was evaluated using transmission electron microscopy (TECNAI 10, Philips, Netherlands).
PCR
Total RNA was extracted from the T-MSCs, V-MSCs, and liver cancer cells using an RNAiso Plus Reagent (TaKaRa, Dalian, China) according to the manufacturer's instructions. PCR amplification was performed using 2 Â Power Taq PCR MasterMix (Bioteke Corporation, Beijing, China) with a GeneAmp PCR system 2700 (PE Applied Biosystems, Shanghai, China). Real-time PCR amplification was performed to determine the mRNA levels of stTRAIL and caspase-3 using SYBR Premix Ex Taq II (TaKaRa) with a LightCycler system (Roche, Mannheim, Germany). The amplification conditions were 95 1C for 30 s, followed by 40 cycles of 95 1C for 5 s, and 60 1C for 20 s, with a final extension at 65 1C for 15 s. The primers used are shown in Tables 1 and 2 . b-actin was used as a control. The mRNA level was assessed using the formula 2 -DDCt , as previously reported. 35 Western blots N1-S1, HepG2, and MHCC97-H cells subjected to experimental conditions were lysed in RIPA Protein Lysis Buffer (P0013B, Beyotime Biotechnology) containing PMSF. Proteins were denatured and separated on a 10% SDS-PAGE and transferred onto a nitrocellulose transfer membrane (Whatman, Piscataway, NJ, USA) using a semidry transfer method (NovaBlot; Pharmacia LKB, New York, NY, USA). The membrane was blocked with trisbuffered saline 0.1% Tween 20 containing 5% skim milk for 1 h at room temperature. It was then incubated with caspase-3 antibody (1:300, sc-7148, Santa Cruz Biotechnology, Heidelberg, Germany) or b-actin antibody (1:5000, Beijing 4A Biotech, China) overnight at 4 1C. The membrane was then incubated for 1 h at room temperature with horseradish peroxidaseconjugated secondary antibody (Santa Cruz Biotechnology) and the band signals were detected using Amersham-enhanced chemiluminescence detection reagents (GE Healthcare Life Sciences, Piscataway, NJ, USA). The chemiluminescence signal was developed in accordance with the manufacturer's protocol (GE Healthcare Life Sciences).
Xenografts in nude mice
T-MSCs, V-MSCs, and L02, and N1-S1 cells were cultured in a cell culture flask (Costar, Corning, NY, USA). A total of 2 Â 10 5 of each type of cell was collected, and the fluorescent dye CM-DiI (Invitrogen) was added to the centrifuge tube and incubated with the T-MSCs, V-MSCs, and L02 cells according to the manufacturer's instructions. Six-to-eight-week old nude mice were divided into five experimental groups (n ¼ 36 volume ¼ length Â width 2 /2. The animals died naturally, and the tumors were excised. Cryostat sections (5 mm) were obtained for fluorescence microscopy analysis and subjected to terminal deoxynucleotidyl transferase dUTP nick end labeling staining. Terminal deoxynucleotidyl transferase dUTP nick end labeling staining was carried out using an In Situ Cell Death Detection Kit POD from Roche.
Statistics
Quantitative data are expressed as the mean ± s.d. and two-tailed w 2 -tests were performed with SPSS13.0 software (SPSS). Differences were considered statistically significant at Po0.05. Survival analysis was performed using the log-rank test. T-MSCs may improve the efficacy of RFA Q Deng et al
